A Reduced 11-b-HSD Activity, a Novel Mechanism of Salt Sensitivity and Hypertension After Renal Allograft Donation?
NCT ID: NCT01009229
Last Updated: 2011-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2009-06-30
2010-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Management of Resistant Hypertension in Kidney Transplant Patients Using Chlorthalidone
NCT02030314
Effect of Dietary Salt Reduction on Blood Pressure in Kidney Transplant Recipients
NCT03373500
Cardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney Donation
NCT01564966
Live Kidney Donor Study -Renal Function Study
NCT01158742
Study on Delayed Graft Function Using Paired Kidneys
NCT01561599
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Low and high salt diets
High salt diet: 150mmol/d Low salt diet: 30mmol/d
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low and high salt diets
High salt diet: 150mmol/d Low salt diet: 30mmol/d
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Insel Gruppe AG, University Hospital Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Berne, Switzerland
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Felix J Frey, Prof
Role: PRINCIPAL_INVESTIGATOR
University of Berne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of nephrology and hypertension, Universitiy of Bern
Bern, Canton of Bern, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Uehlinger-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.